Clinical Trial Update: Study of CT071 Injection in RRMM or PPCL [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update for CT071 injection in relapsed/refractory multiple myeloma and primary plasma cell leukemia; early-phase 1 study currently active and not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Leukemia

Drugs mentioned

• CT071

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Multiple Myeloma, Primary Plasma Cell Leukemia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING